Results from clinical phase I study on breast tumor ablation with dedicated breast MR-HIFU system

We have recently conducted a clinical phase I study to assess the safety and spatial accuracy and precision of a newly developed dedicated MR-HIFU system for lateral breast tumor ablation [1]. Here, we report on patient inclusion, treatment efficacy and safety.